You are here

WPD Pharmaceuticals Inc.

WPD Pharmaceuticals Inc.
Listing Exchange: 
CSE
Status: 
Suspended
Industry: 
Life Sciences
Symbol: 
WBIO
CSE Index: 
Currency: 

WPD Pharmaceuticals is a biotechnology research and development company. The Company operates in the pharmaceuticals industry with a focus on oncology, namely research and development of medicinal products involving biological compounds and small molecules. The Issuer is developing drugs which were researched at institutions including MD Anderson Cancer Center, Mayo Clinic and Emory University, and has ongoing collaborations with Wake Forest University and leading hospitals and academic centers in Poland.

You are here

WPD Pharmaceuticals Inc. (WBIO)

SEDAR Information

Company Info

Address
750 West Pender Street, Suite 401
Vancouver, BC V6C 2T7
Canada
Phone
604-561-2687
Fax
604-565-3332
Email
michael.malana@wpdpharmaceuticals.com
Listing date
Friday, December 27, 2019
Transfer Agent
Computershare Investor Services Inc.

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
111,520,388
Reserved for Issuance: 
3,949,997

Bulletins

11/07/2022

2022-0708 – Suspensions (MCCN, MEAL, WBIO, TELE, GBMC, CBDN)

Le 11 juillet/July 2022

Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules.  Cease Trade Orders have been issued by one or more securities commissions. 

Advertisement

Publicité

Latest CSE News

Upcoming Events

2022-11-28-Saskatchewan-Geological-Open-House_Website.jpg

Saskatchewan Geological Open House

Monday, November 28, 2022 - 1:00pm to Wednesday, November 30, 2022 - 5:00pm
2022-12-01-Toronto-Investor-Series-at-The-Albany-Club_Website.jpg

Toronto Investor Series at The Albany Club

Thursday, December 1, 2022 -
1:00pm to 5:30pm